Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Large-Cap Stocks to Consider Right Now

By: StockStory

May 21, 2026 at 00:35 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

RMD Cover Image

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.

This dynamic can trouble even the most skilled investors, but luckily for you, we started StockStory to help you navigate these trade-offs and uncover exceptional companies that break the mold. Keeping that in mind, here are three large-cap stocks with attractive long-term potential.

ResMed (RMD)

Market Cap: $30.44 billion

Founded in 1989 to address the then-underdiagnosed condition of sleep apnea, ResMed (NYSE: RMD) develops cloud-connected medical devices and software solutions that treat sleep apnea, COPD, and other respiratory disorders for home and clinical use.

Why Are We Fans of RMD?

Constant currency growth averaged 9.1% over the past two years, showing it can expand globally regardless of the macroeconomic environment
Additional sales over the last five years increased its profitability as the 15.2% annual growth in its earnings per share outpaced its revenue
Free cash flow margin grew by 21.4 percentage points over the last five years, giving the company more chips to play with

ResMed is trading at $211.32 per share, or 17.4x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.

Ameriprise Financial (AMP)

Market Cap: $41.11 billion

Founded in 1894 and spun off from American Express in 2005, Ameriprise Financial (NYSE: AMP) provides financial planning, wealth management, asset management, and insurance products to help individuals and institutions achieve their financial goals.

Why Do We Love AMP?

Share repurchases have amplified shareholder returns as its annual earnings per share growth of 23.9% exceeded its revenue gains over the last five years
Impressive 18.7% annual tangible book value per share growth over the last two years indicates it’s building equity value this cycle
Industry-leading 63.7% return on equity demonstrates management’s skill in finding high-return investments

Ameriprise Financial’s stock price of $457.32 implies a valuation ratio of 10.5x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.

Allstate (ALL)

Market Cap: $57.14 billion

Born from a Sears, Roebuck & Co. initiative during the Great Depression with its famous "You're in good hands" slogan, Allstate (NYSE: ALL) is one of America's largest personal property and casualty insurers, offering protection for autos, homes, and personal property.

Why Does ALL Stand Out?

Offerings and unique value proposition resonate with customers, as seen in its above-market 9.6% annual sales growth over the last five years
Performance over the past two years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
Balance sheet strength has increased this cycle as its 34.9% annual book value per share growth over the last two years was exceptional

At $221.91 per share, Allstate trades at 1.8x forward P/B. Is now a good time to buy? See for yourself in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	253.79	+3.77 (1.51%)
AAPL	311.23	+0.97 (0.31%)
AMD	523.20	-19.32 (-3.56%)
BAC	54.17	+1.77 (3.38%)
GOOG	369.27	+13.59 (3.82%)
META	627.57	+4.59 (0.74%)
MSFT	428.05	+0.71 (0.17%)
NVDA	218.66	+3.91 (1.82%)
ORCL	236.34	+6.01 (2.61%)
TSLA	418.45	-5.25 (-1.24%)